Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer

British Journal of Cancer

Volumn 96, Issue 1, 2007, Pages 104-109

  Hussain, S A ^a   Ganesan, R ^b   Reynolds, G ^c   Gross, L ^a   Stevens, A ^d   Pastorek, J ^e   Murray, P G ^a   Perunovic, B ^f   Anwar, M S ^d   Billingham, L ^a   James, N D ^a   Spooner, D ^d   Poole, C J ^a   Rea, D W ^a   Palmer, D H ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e INSTITUTE OF VIROLOGY   (Slovakia)

^f WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Carbonic anhydrase (CA IX); Hypoxia; Prognostic marker

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARBONIC ANHYDRASES; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STAINING AND LABELING; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846211525     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603530     Document Type: Article

References (30)

1. Brizel DM, Rosner GL, Prosnitz LR, Dewhirst MW (1995) Patterns and variability of tumour oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int J Radiat Oncol Biol Phys 32: 1121-1125
2. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW (1996) Tumour oxygenation predicts for likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943
3. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660-3668
4. Cox DR (1972) Regression models and life tables. J Roy Statist Soc (B) 34: 187-220
5. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill R (2002) Tumour hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687
6. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ, Hill RP (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48: 149-156
7. Galea MH, Blamey RW, Elston CW, Ellis IO (1992) The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22: 207-219
8. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91
9. 2 histography as predictive assay in advanced cancer of the uterine cervix. Adv Exp Med Biol 345: 445-450
10. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P (1996) Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515
11. Hoskin PJ, Sibtain A, Daley FM, Wilson GD (2003) GLUT1 and CA IX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89(7): 1290-1297
12. Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Pastorek J, Murray P, Young LS, James ND (2004) Role of hypoxic marker CA IX in transitional cell carcinoma of the bladder. Oncol Rep 11: 1005-1010
13. Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ (2002) Pimonidazole binding and tumour vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62(23): 7066-7074
14. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Statist Assoc 53: 457-481
15. Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, Di Paulo JA, Peehl DM, Giaccia AJ (1997) Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res 57: 4200-4204
16. 2 measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 53: 99-104
17. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wykoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61: 6394-6399
18. Mayer A, Hoc̈kel M, Vaupel P (2005) Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin Cancer Res 11: 7220-7225
19. Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, Timms J, Rowlands D, McConkey C, Reynolds GM, Ghataura S, England D, Caroll R, Young LS (2003) Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 63: 2338-2343
20. Nordsmark M, Overgaard M, Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39
21. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J (1992) A novel quasi-viral agent, Ma Tu, is a two-component system. Virology 187: 620-626
22. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient II. Analysis and example. Br J Cancer 35: 1-39
23. Reynolds GM, Billingham LJ, Gray LJ, Flavell JR, Najafipour S, Crocker J, Nelson P, Young LS, Murray PG (2002) Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptons and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br J Haematol 118(1): 195-201
24. Reynolds TY, Rockwell S, Glazer PM (1996) Genetic instability induced by the tumour microenvironment. Cancer Res 56: 5754-5757
25. Svastova E, Hulikova A, Rafajova M, Zat'ovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekova S (2004) Hypoxia activates the capacity of tumour-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577(3): 439-445
26. Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumour hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21(3): 473-482
27. Tsoli E, Tsantoulis PK, Perunovic B, England D, Rawlands D, Reynolds GM, Vlachodimitropoulos D, Morgan S, Papalambros A, Spiliopoulou C, Athanasiou T, Gorgoulis VG (2006) Simultaneous evaluation of Maspin and CXCR4 in breast cancer patients. Clin Pathol Epub ahead of print
28. Turner KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, Pastorek J, Ratcliffe PJ, Cranston D, Harris AL (2002) The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer 86(8): 1276-1282
29. 2 tension measurements. Cancer Res 51(12): 3316-3322
30. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumour-associated carbonic anhydrases. Cancer Res 60(24): 7075-7083